MA40908B1 - Anticorps anti-il-6 améliorés - Google Patents

Anticorps anti-il-6 améliorés

Info

Publication number
MA40908B1
MA40908B1 MA40908A MA40908A MA40908B1 MA 40908 B1 MA40908 B1 MA 40908B1 MA 40908 A MA40908 A MA 40908A MA 40908 A MA40908 A MA 40908A MA 40908 B1 MA40908 B1 MA 40908B1
Authority
MA
Morocco
Prior art keywords
antibodies
improved anti
relates
treatment
macular edema
Prior art date
Application number
MA40908A
Other languages
English (en)
Inventor
Michael March Schmidt
Alison Tisdale
Eric Furfine
Grigorios Zarbis-Papastoitsis
Original Assignee
Sesen Bio Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sesen Bio Inc filed Critical Sesen Bio Inc
Priority claimed from PCT/US2015/059532 external-priority patent/WO2016073890A1/fr
Publication of MA40908B1 publication Critical patent/MA40908B1/fr

Links

Landscapes

  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)

Abstract

L'invention concerne des anticorps anti-il-6 améliorés. L'invention concerne des utilisations des anticorps dans le traitement de maladies associées à il -6, par exemple, des maladies oculaires telles que l'œdème maculaire diabétique.
MA40908A 2014-11-07 2015-11-06 Anticorps anti-il-6 améliorés MA40908B1 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201462077105P 2014-11-07 2014-11-07
PCT/US2015/059532 WO2016073890A1 (fr) 2014-11-07 2015-11-06 Anticorps anti-il-6 améliorés

Publications (1)

Publication Number Publication Date
MA40908B1 true MA40908B1 (fr) 2019-11-29

Family

ID=69155916

Family Applications (1)

Application Number Title Priority Date Filing Date
MA40908A MA40908B1 (fr) 2014-11-07 2015-11-06 Anticorps anti-il-6 améliorés

Country Status (1)

Country Link
MA (1) MA40908B1 (fr)

Similar Documents

Publication Publication Date Title
SA519401522B1 (ar) Lag-3 أجـسـام مـضـادة لـ وتـركـيـبـات
MA42471B1 (fr) Compositions comprenant des souches bactériennes
MA41060A (fr) Compositions comprenant des souches bactériennes
MA44322A (fr) Compositions comprenant des souches bactériennes
MX2021008663A (es) Anticuerpos mejorados contra il-6.
MA55434B1 (fr) Compositions comprenant des souches bactériennes
EA201890747A1 (ru) Способы лечения воспалительных заболеваний
MA41010A (fr) Compositions comprenant des souches bactériennes
EA201992546A1 (ru) Средства на основе антител к cd33
CR20170060A (es) Anticuerpos anti tigit
EA201792616A1 (ru) Средства, пути применения и способы лечения синуклеопатии
MA40576A (fr) Anticorps et immunoconjugués anti-her2
FR3021970B1 (fr) Anticorps dirige contre la galectine 9 et inhibiteur de l'activite suppressive des lymphocytes t regulateurs
CO2017008455A2 (es) Anticuerpos contra tau
MA52216B1 (fr) Mirikizumab pour le traitement de la colite ulcéreuse
EA201791710A1 (ru) Антитела к транстиретину
JOP20220119A1 (ar) أجسام مضادة trem2 واستخداماتها
EA201692109A1 (ru) Варианты антител к фактору d и их применение
EA201791711A1 (ru) Антитела к транстиретину
MX2022011972A (es) Composiciones que comprenden anticuerpos contra il6r para el tratamiento de la uveitis y el edema macular, y metodos de uso de las mismas.
EA201692402A1 (ru) Лекарственные формы для местного применения и их использование
UY36262A (es) Anticuerpos anti proteína similar a angiopoyetina 4 y métodos de uso
FR3019465B1 (fr) Composition hyperosmolaire d'acide hyaluronique et son utilisation pour le traitement de l'oedeme corneen
MX374705B (es) Composiciones que comprenden anakinra.
MA40908B1 (fr) Anticorps anti-il-6 améliorés